Phospholipid compounds and formulations
US10953023B1 · kind B1 · utility
2Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2020 |
| Grant date | Mar 23, 2021 |
| Priority date | — |
| Expiry date | Jan 28, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/663
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.